title: [Iliofascial versus epidural block during hip endoprosthesis].
abstract: The study was carried out to compare analgesia, the side-effects incidence and the need for analgetics when you use the continuous iliofascial block (CIFB) versus epidural analgesia (EA) after the total hip joint endoprosthesis (THJEP). 60 patients undergoing planned THJEP under spinal anaesthesia were included in a randomized controlled study. The day before the surgery all patients were divided into 2 groups (30 people each). In the 1st group postoperative analgesia carried out on the basis of the EA, and in the 2nd group - CIFB. All patients received balanced analgesia with nonopioid analgesics, and in case of pain syndrome - tramadol injections. In the 1-st group the value of the visual-analogue scale - VAS (0-100mm) 6 h after the operation was significantly lower at rest and in motion. The maximum average value of VAS in motion was 2.3 +/- 2, 1 mm in EA group and 3.2 +/- 2.6 mm in CIFB group. Frequency of tramadol use in 1-st and 2-nd groups was 6.9% and 41.4%, and of nausea - 34,5% and 6.9%, respectively. Patient analgesia satisfaction was higher in the 2nd group.
  
  
  CONCLUSIONS
  Extended IFB provides a good level of analgesia in patients after THJEP. Prolonged EA exceeds CIFB in analgesia, but is accompanied by a greater frequency of postoperative nausea occurrence.
authors.forename: D B
authors.initials: DB
authors.lastname: Borisov
authors.forename: A A
authors.initials: AA
authors.lastname: Kapinos
authors.forename: A A
authors.initials: AA
authors.lastname: Tiuriapin
authors.forename: A V
authors.initials: AV
authors.lastname: Shevelev
authors.forename: N A
authors.initials: NA
authors.lastname: Istomina
mesh_terms: D015360:Analgesia, Epidural / Q000379:methods*; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D001340:Autonomic Nerve Block / Q000379:methods*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D010149:Postoperative Pain / Q000517:prevention & control*; D017060:Patient Satisfaction; D020250:Postoperative Nausea and Vomiting / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D014147:Tramadol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D014147:Tramadol